wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37636802-4769F217-5285-4BF2-AC13-FDD4D72D8F9F
Q37636802-4769F217-5285-4BF2-AC13-FDD4D72D8F9F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37636802-4769F217-5285-4BF2-AC13-FDD4D72D8F9F
A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinoma
P2860
Q37636802-4769F217-5285-4BF2-AC13-FDD4D72D8F9F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37636802-4769F217-5285-4BF2-AC13-FDD4D72D8F9F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e4f739d1f3276c82c9039a9efe6e14f74fb7e01a
P2860
Predictors of the response to gefitinib in refractory non-small cell lung cancer.